Request Deal Involvement

Johnson & Johnson completed the acquisition of Ambrx for $1.9bn.

Identify your role

Select the side you represented in this transaction, and provide your current job title.

Service Providers

Cravath Swaine & Moore

legal advisors

Cravath Swaine & Moore

Freshfields Bruckhaus Deringer

legal advisors

Freshfields Bruckhaus Deringer

Paul Weiss Rifkind Wharton & Garrison

legal advisors to financial advisors

Paul Weiss Rifkind Wharton & Garrison

Centerview Partners

financial advisors

Centerview Partners

Skadden Arps Slate Meagher & Flom

legal advisors

Skadden Arps Slate Meagher & Flom

Collected Strategies

pr advisors

Collected Strategies

LifeSci Partners

financial advisors

LifeSci Partners

or

Principals

JOHNSON & JOHNSON

bidder

JOHNSON & JOHNSON

AMBRX INC

target

AMBRX INC

Principals or Service Provider not listed?Add missing Service Provider or Principal

Enter your Job Title on this deal

This title will appear on your profile next to this deal involvement.


To help us verify your involvement, please include links to any relevant publications that mention you or your company's role in this deal:

All rights reserved. Copyright © 2025 Datasite

MergerLinks - Request Credit - Johnson & Johnson completed the acquisition of Ambrx for $1.9bn.